230 related articles for article (PubMed ID: 10692757)
41. [Early percutaneous revascularization in patients with unstable angina. Current results and comparison with conservative medical treatment].
Bethencourt A; Fernández-Palomeque C; Gómez-Jaume A; Peral V
Rev Esp Cardiol; 1999; 52 Suppl 1():117-30. PubMed ID: 10364821
[TBL] [Abstract][Full Text] [Related]
42. IIb/IIIa Receptor Blockers. Preface.
van den Brand M; O'Neill W
Semin Interv Cardiol; 1999 Jun; 4(2):59-60. PubMed ID: 10473873
[No Abstract] [Full Text] [Related]
43. Antithrombotic treatment of acute coronary syndromes.
Théroux P
Can J Cardiol; 1998 Aug; 14 Suppl E():6E-10E. PubMed ID: 9779026
[TBL] [Abstract][Full Text] [Related]
44. Lotrafiban: an oral platelet glycoprotein IIb/IIIa blocker.
Liu F; Craft RM; Morris SA; Carroll RC
Expert Opin Investig Drugs; 2000 Nov; 9(11):2673-87. PubMed ID: 11060829
[TBL] [Abstract][Full Text] [Related]
45. Antiplatelet treatment in unstable angina: aspirin, clopidogrel, glycoprotein IIb/IIIa antagonist, or all three?
Harding SA; Boon NA; Flapan AD
Heart; 2002 Jul; 88(1):11-4. PubMed ID: 12067932
[TBL] [Abstract][Full Text] [Related]
46. [Cardiology. II. Coronary heart disease, myocardial infarction].
Rupprecht HJ
Arzneimittelforschung; 1997 Nov; 47(11):1282-8. PubMed ID: 9463304
[TBL] [Abstract][Full Text] [Related]
47. Trials of glycoprotein IIb-IIIa inhibitors in non-ST-segment elevation acute coronary syndromes: applicability to the practice of medicine in the United States.
Cohen M; Ferguson JJ; Harrington RA
Clin Cardiol; 1999 Oct; 22 Suppl 6(Suppl 6):VI2-12. PubMed ID: 10526702
[TBL] [Abstract][Full Text] [Related]
48. Clinical trials of glycoprotein IIb/IIIa inhibitors.
Talley JD
J Interv Cardiol; 2001 Apr; 14(2):129-42. PubMed ID: 12053294
[TBL] [Abstract][Full Text] [Related]
49. New concepts for the treatment of unstable angina: role for intravenous diltiazem.
Boden WE
J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S1-6. PubMed ID: 1725535
[TBL] [Abstract][Full Text] [Related]
50. Antiplatelet medications and their indications in preventing and treating coronary thrombosis.
Van De Graaff E; Steinhubl SR
Ann Med; 2000 Nov; 32(8):561-71. PubMed ID: 11127934
[TBL] [Abstract][Full Text] [Related]
51. Use of glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing coronary revascularization.
Popma JJ
Haemostasis; 1999 Dec; 29 Suppl S1():69-71. PubMed ID: 10629407
[TBL] [Abstract][Full Text] [Related]
52. Glycoprotein IIb/IIIa antagonists--from bench to practice.
Casserly IP; Topol EJ
Cell Mol Life Sci; 2002 Mar; 59(3):478-500. PubMed ID: 11964126
[TBL] [Abstract][Full Text] [Related]
53. [New therapeutic prospects in acute coronary thrombosis].
Roux S
Arch Mal Coeur Vaiss; 1995 Jan; 88(1):91-4. PubMed ID: 7646255
[TBL] [Abstract][Full Text] [Related]
54. Clinical management of unstable angina: the place of antithrombins and platelet GP IIb/IIIa receptor blockers.
Knudtson ML
Eur Heart J; 1995 Nov; 16 Suppl L():68-74. PubMed ID: 8869022
[TBL] [Abstract][Full Text] [Related]
55. Optimal timing for use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: questions, answers, and more questions.
Mahaffey KW; Harrington RA
JAMA; 2007 Feb; 297(6):636-9. PubMed ID: 17299199
[No Abstract] [Full Text] [Related]
56. Platelet glycoprotein IIb/IIIa receptor antagonists: current concepts and future directions.
Ferguson JJ; Zaqqa M
Drugs; 1999 Dec; 58(6):965-82. PubMed ID: 10651385
[TBL] [Abstract][Full Text] [Related]
57. [Evaluation of a selective strategy for glycoprotein IIb/IIIa inhibitors administration in non-ST segment elevation acute coronary syndromes].
Georges JL; Charbonnel C; Convers-Domart R; Baron N; Leterme C; Galuscan G; Schwob J; Livarek B
Ann Cardiol Angeiol (Paris); 2010 Nov; 59(5):271-7. PubMed ID: 20888551
[TBL] [Abstract][Full Text] [Related]
58. Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus.
Kereiakes DJ; Montalescot G; Antman EM; Cohen M; Darius H; Ferguson JJ; Grines C; Karsch KR; Kleiman NS; Moliterno DJ; Steg PG; Teirstein P; Van de Werf F; Wallentin L
Am Heart J; 2002 Oct; 144(4):615-24. PubMed ID: 12360156
[TBL] [Abstract][Full Text] [Related]
59. Management of high-risk subsets in unstable angina.
Tung C; Sauri D; Fintel D; Gheorghiade M
Cardiol Clin; 1999 May; 17(2):415-37, x. PubMed ID: 10384836
[TBL] [Abstract][Full Text] [Related]
60. GP IIb/IIIa antagonists. Clinical experience and potential uses in cardiology.
Kleiman NS
Drugs R D; 1999 May; 1(5):361-70. PubMed ID: 10566065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
